세계의 무세포 단백질 발현 시장 성장, 규모, 동향 분석 : 제품, 용도, 방법, 최종사용자별 - 지역별 전망, 경쟁 전략, 부문 예측(-2034년)

Global Cell-Free Protein Expression Market Introduction and Overview

According to SPER market research, 'Global Cell-Free Protein Expression Market Size-By Product, By Application, By Method, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Cell-Free Protein Expression Market is predicted to reach 680.32 million by 2034 with a CAGR of 8.86%.

Cell-free protein expression, proteins can be synthesized in vitro without the use of living cells. Instead of depending on the cellular machinery of whole organisms, this technique employs extracted components-such as ribosomes, tRNAs, amino acids, and enzymes-from sources like E. coli, wheat germ, or insect cells. These components preserve the ability to transcribe DNA into RNA and translate RNA into proteins, enabling researchers to generate proteins rapidly and in a controlled environment.

Restraints: The limited scalability of the global cell-free protein expression market poses a major challenge. While cell-free systems work well for small-scale applications, they often struggle to generate the high yields needed for industrial production. This leads to economic difficulties for large-scale synthesis due to the need for extensive optimization and the use of costly reagents in significant amounts.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Application, By Method, By End Use

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

biotechrabbit, CellFree Sciences Co., Ltd., GeneCopoeia, Inc., Jena Bioscience GmbH, Merck KGaA, New England Biolabs, Promega Corporation, Takara Bio Inc., Thermo Fisher Scientific, Inc.

Global Cell-Free Protein Expression Market Segmentation:

By Product: Based on the Product, Global Cell-Free Protein Expression Market is segmented as; Expression Systems, Reagents.

By Application: Based on the Application, Global Cell-Free Protein Expression Market is segmented as; Enzyme Engineering, High Throughput Production, Protein Labelling, Protein-Protein Interaction, Protein Purification.

By Method: Based on the Method, Global Cell-Free Protein Expression Market is segmented as; Transcription & Translation systems, Translation systems.

By End Use: Based on the End Use, Global Cell-Free Protein Expression Market is segmented as; Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1.Introduction

• 1.1.Scope of the report
• 1.2.Market segment analysis

2.Research Methodology

• 2.1.Research data source
  • 2.1.1.Secondary Data
  • 2.1.2.Primary Data
  • 2.1.3.SPERs internal database
  • 2.1.4.Premium insight from KOLs
• 2.2.Market size estimation
  • 2.2.1.Top-down and Bottom-up approach
• 2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

• 4.1.Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1.Drivers
  • 4.1.2.Restraints
  • 4.1.3.Opportunities
  • 4.1.4.Challenges

5.Market variable and outlook

• 5.1.SWOT Analysis
  • 5.1.1.Strengths
  • 5.1.2.Weaknesses
  • 5.1.3.Opportunities
  • 5.1.4.Threats
• 5.2.PESTEL Analysis
  • 5.2.1.Political Landscape
  • 5.2.2.Economic Landscape
  • 5.2.3.Social Landscape
  • 5.2.4.Technological Landscape
  • 5.2.5.Environmental Landscape
  • 5.2.6.Legal Landscape
• 5.3.PORTERs Five Forces
  • 5.3.1.Bargaining power of suppliers
  • 5.3.2.Bargaining power of buyers
  • 5.3.3.Threat of Substitute
  • 5.3.4.Threat of new entrant
  • 5.3.5.Competitive rivalry
• 5.4.Heat Map Analysis

6.Competitive Landscape

• 6.1.Global Cell- Free Protein Expression Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cell- Free Protein Expression Market

7.Global Cell- Free Protein Expression Market, By Product (USD Million) 2021-2034

• 7.1.Expression Systems
• 7.2.Reagents

8.Global Cell- Free Protein Expression Market, By Application (USD Million) 2021-2034

• 8.1.Enzyme Engineering
• 8.2.High Throughput Production
• 8.3.Protein Labeling
• 8.4.Protein-Protein Interaction
• 8.5.Protein Purification

9.Global Cell- Free Protein Expression Market, By Method (USD Million) 2021-2034

• 9.1.Transcription & Translation systems
• 9.2.Translation systems

10.Global Cell- Free Protein Expression Market, By End Use (USD Million) 2021-2034

• 10.1.Pharmaceutical and Biotechnology Companies
• 10.2.Academic and Research Institutes
• 10.3.Others

11.Global Cell- Free Protein Expression Market, (USD Million) 2021-2034

• 11.1.Global Cell- Free Protein Expression Market Size and Market Share

12.Global Cell- Free Protein Expression Market, By Region, (USD Million) 2021-2034

• 12.1.Asia-Pacific
  • 12.1.1.Australia
  • 12.1.2.China
  • 12.1.3.India
  • 12.1.4.Japan
  • 12.1.5.South Korea
  • 12.1.6.Rest of Asia-Pacific
• 12.2.Europe
  • 12.2.1.France
  • 12.2.2.Germany
  • 12.2.3.Italy
  • 12.2.4.Spain
  • 12.2.5.United Kingdom
  • 12.2.6.Rest of Europe
• 12.3.Middle East and Africa
  • 12.3.1.Kingdom of Saudi Arabia
  • 12.3.2.United Arab Emirates
  • 12.3.3.Qatar
  • 12.3.4.South Africa
  • 12.3.5.Egypt
  • 12.3.6.Morocco
  • 12.3.7.Nigeria
  • 12.3.8.Rest of Middle-East and Africa
• 12.4.North America
  • 12.4.1.Canada
  • 12.4.2.Mexico
  • 12.4.3.United States
• 12.5.Latin America
  • 12.5.1.Argentina
  • 12.5.2.Brazil
  • 12.5.3.Rest of Latin America

13.Company Profile

• 13.1.biotechrabbit
  • 13.1.1.Company details
  • 13.1.2.Financial outlook
  • 13.1.3.Product summary
  • 13.1.4.Recent developments
• 13.2.CellFree Sciences Co., Ltd
  • 13.2.1.Company details
  • 13.2.2.Financial outlook
  • 13.2.3.Product summary
  • 13.2.4.Recent developments
• 13.3.GeneCopoeia, Inc.
  • 13.3.1.Company details
  • 13.3.2.Financial outlook
  • 13.3.3.Product summary
  • 13.3.4.Recent developments
• 13.4.Jena Bioscience GmbH
  • 13.4.1.Company details
  • 13.4.2.Financial outlook
  • 13.4.3.Product summary
  • 13.4.4.Recent developments
• 13.5.Merck KGaA,
  • 13.5.1.Company details
  • 13.5.2.Financial outlook
  • 13.5.3.Product summary
  • 13.5.4.Recent developments
• 13.6.New England Biolabs
  • 13.6.1.Company details
  • 13.6.2.Financial outlook
  • 13.6.3.Product summary
  • 13.6.4.Recent developments
• 13.7.Promega Corporation
  • 13.7.1.Company details
  • 13.7.2.Financial outlook
  • 13.7.3.Product summary
  • 13.7.4.Recent developments
• 13.8.Takara Bio Inc.
  • 13.8.1.Company details
  • 13.8.2.Financial outlook
  • 13.8.3.Product summary
  • 13.8.4.Recent developments
• 13.9.Thermo Fisher Scientific, Inc.
  • 13.9.1.Company details
  • 13.9.2.Financial outlook
  • 13.9.3.Product summary
  • 13.9.4.Recent developments
• 13.10.Others

14.Conclusion

15.List of Abbreviations

16.Reference Links